Publications by authors named "Pedro Ivo de Marqui Moraes"
Metrics of care and cardiovascular outcomes in patients with ST-elevation myocardial infarction treated with pharmacoinvasive strategy: a decade-long network in a populous city in Brazil.
BMC Cardiovasc Disord
June 2023
Background: Pharmacoinvasive strategy is an effective myocardial reperfusion therapy when primary percutaneous coronary intervention (p-PCI) cannot be performed in a timely manner.
Methods: Authors sought to evaluate metrics of care and cardiovascular outcomes in a decade-long registry of a pharmacoinvasive strategy network for the treatment of ST-elevation myocardial infarction (STEMI). Data from a local network including patients undergoing fibrinolysis in county hospitals and systematically transferred to the tertiary center were accessed from March 2010 to September 2020.
Pharmaco-invasive Strategy in Myocardial Infarction: Descriptive Analysis, Presentation of Ischemic Symptoms and Mortality Predictors.
Arq Bras Cardiol
November 2022
Background: ST-segment elevation myocardial infarction (STEMI) is defined by symptoms accompanied by typical electrocardiogram changes. However, the characterization of ischemic symptoms is unclear, especially in subgroups such as women and the elderly.
Objectives: To analyze the typification of ischemic symptoms, temporal metrics and observe the occurrence of in-hospital outcomes, in the analysis of predictive scores, in patients with STEMI, in a drug-invasive strategy.
Article Synopsis
- Primary percutaneous coronary intervention is ideal for coronary reperfusion, but when it's unavailable, drug treatments along with ECG are used to assess success.
- This study looked at ST-Segment changes after fibrinolysis to see how well they predict successful blood flow restoration based on angiographic scores.
- Findings revealed that ST-Segment reduction had limited effectiveness in identifying proper reperfusion, suggesting that further angiographic evaluation is necessary even when ECG appears positive.